Search research articles
Contact Us
Filters
Showing results (31-40 of 39) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 39 results.
Journal for Immunotherapy of Cancer
|
November 30, 2016
Validation of biomarkers to predict response to immunotherapy in cancer: Volume I - pre-analytical and analytical validation
Giuseppe V Masucci, Alessandra Cesano, Rachael Hawtin, et al.
Cancer Immunology, Immunotherapy : CII
|
November 7, 2009
Performance of serum-supplemented and serum-free media in IFNgamma Elispot Assays for human T cells
Sylvia Janetzki, L Price, C M Britten, et al.
Frontiers in Immunology
|
January 25, 2021
Photochemical Internalization Enhanced Vaccination Is Safe, and Gives Promising Cellular Immune Responses to an HPV Peptide-Based Vaccine in a Phase I Clinical Study in Healthy Volunteers
Tone Otterhaug, Sylvia Janetzki, Marij J P Welters, et al.
Journal for Immunotherapy of Cancer
|
December 3, 2020
SITC cancer immunotherapy resource document: a compass in the land of biomarker discovery
Siwen Hu-Lieskovan, Srabani Bhaumik, Kavita Dhodapkar, et al.
The AAPS Journal
|
January 6, 2026
Assessment of Immune Responses Against AAV Encoded Transgene Products
Boris Gorovits, Mitra Azadeh, Michele Fiscella, et al.
Journal for Immunotherapy of Cancer
|
June 28, 2017
Immunotherapy biomarkers 2016: overcoming the barriers
James L Gulley, Jay A Berzofsky, Marcus O Butler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 12, 2011
Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers
Lisa H Butterfield, A Karolina Palucka, Cedrik M Britten, et al.
Journal of Translational Medicine
|
December 25, 2008
A systematic approach to biomarker discovery; preamble to "the iSBTc-FDA taskforce on immunotherapy biomarkers"
Lisa H Butterfield, Mary L Disis, Bernard A Fox, et al.
Journal of Translational Medicine
|
December 16, 2011
Defining the critical hurdles in cancer immunotherapy
Bernard A Fox, Dolores J Schendel, Lisa H Butterfield, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 39) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 39 results.
Journal for Immunotherapy of Cancer
|
November 30, 2016
Validation of biomarkers to predict response to immunotherapy in cancer: Volume I - pre-analytical and analytical validation
Giuseppe V Masucci, Alessandra Cesano, Rachael Hawtin, et al.
Cancer Immunology, Immunotherapy : CII
|
November 7, 2009
Performance of serum-supplemented and serum-free media in IFNgamma Elispot Assays for human T cells
Sylvia Janetzki, L Price, C M Britten, et al.
Frontiers in Immunology
|
January 25, 2021
Photochemical Internalization Enhanced Vaccination Is Safe, and Gives Promising Cellular Immune Responses to an HPV Peptide-Based Vaccine in a Phase I Clinical Study in Healthy Volunteers
Tone Otterhaug, Sylvia Janetzki, Marij J P Welters, et al.
Journal for Immunotherapy of Cancer
|
December 3, 2020
SITC cancer immunotherapy resource document: a compass in the land of biomarker discovery
Siwen Hu-Lieskovan, Srabani Bhaumik, Kavita Dhodapkar, et al.
The AAPS Journal
|
January 6, 2026
Assessment of Immune Responses Against AAV Encoded Transgene Products
Boris Gorovits, Mitra Azadeh, Michele Fiscella, et al.
Journal for Immunotherapy of Cancer
|
June 28, 2017
Immunotherapy biomarkers 2016: overcoming the barriers
James L Gulley, Jay A Berzofsky, Marcus O Butler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 12, 2011
Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers
Lisa H Butterfield, A Karolina Palucka, Cedrik M Britten, et al.
Journal of Translational Medicine
|
December 25, 2008
A systematic approach to biomarker discovery; preamble to "the iSBTc-FDA taskforce on immunotherapy biomarkers"
Lisa H Butterfield, Mary L Disis, Bernard A Fox, et al.
Journal of Translational Medicine
|
December 16, 2011
Defining the critical hurdles in cancer immunotherapy
Bernard A Fox, Dolores J Schendel, Lisa H Butterfield, et al.
Page
of 4